About Company
- Legal Name: Regenix drugs Ltd
- Registered country: India
- Address: B-26, Phase -II, Zone B ,MEPZ -SEZ, Tambaram, , Tamilnadu
- Number of employees: 50 - 99
- Established year: 2007
Description:
Regenix is a biosimilar injection formulation and fill-finish manufacturing facility located in Chennai, India. A WHO-GMP-accredited, state-of-the-art facility spanning 30,000 square feet, designed to the latest GMP regulatory standards to fill sterile products in vials, pre-filled syringes and cartridges, the company's current CTD-format dossier product list includes human insulin injection (R, 30/70 and NPH), Insulin Glargine, Liraglutide and Enoxaparin Sodium injections.
Business Activities
Finished Dosage Forms
Manufacturer
Biopharmaceutical Products
Manufacturer
ATC (Anatomical Therapeutic Chemical) Classification
Manufacturer
Sales Markets
- South Asia: , , ,
Our Products & Services
Certifications
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment